Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NorthStar™ Mapping System

K-Number: K252164 · 2026-01-28

Decision Date2026-01-28
Product CodeDQK
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

NorthStar™ Mapping System is a medical device manufactured by Imricor Medical Systems. It received FDA 510(k) clearance on 2026-01-28 under approval number K252164. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NorthStar™ Mapping System?

NorthStar™ Mapping System is a medical device that received FDA 510(k) clearance on 2026-01-28. It is manufactured by Imricor Medical Systems. The 510(k) number is K252164.

When was NorthStar™ Mapping System approved by the FDA?

NorthStar™ Mapping System received FDA 510(k) clearance on 2026-01-28, under approval number K252164.

What company makes NorthStar™ Mapping System?

NorthStar™ Mapping System is manufactured by Imricor Medical Systems.

What is the FDA product code for NorthStar™ Mapping System?

The FDA product code for NorthStar™ Mapping System is DQK.

Related Clinical Trials

Related Devices (Code: DQK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.